2 reports

  • SEP 01, 2017: AUTOIMMUNE DISEASE USE PATENT FOR EP4 ANTAGONIST APPROVED IN KOREA

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2018 Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Prostaglandin E2 receptor 4 (EP4) is a prostaglandin receptor encoded by the PTGER4 gene. The activity of the receptor...

  • Autoimmune Disease
  • China
  • World
  • Product Initiative
  • Eisai Co., Ltd.

R& D Progress Research and Development Brief Phase II - Trial Details E-## Product Description E-## (KANAb-##) is under development for the treatment of autoimmune inflammatory diseases including Crohn' s disease and rheumatoid arthritis.

  • Autoimmune Disease
  • Infectious Disease
  • Research And Development
  • Therapy
  • Eisai Co., Ltd.